Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, 6207, Switzerland
NCT Number: NCT02179073
Bladder management has a major impact on the quality of life in patients with neurogenic bladder dysfunction. This a prospective investigation of the effects of the method for bladder evacuation on the health-related quality of life in patients with neurogenic bladder dysfunction. The changes in health-related quality of life over time (longitudinal investigation) and the differences between the different methods for bladder evacuation will be investigated. Patients will be given a standardized and validated questionnaire annually for 10 years.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nottwil, Canton of Lucerne, 6207, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to year 10
Qualiveen questionnaire
Time frame: year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
method for bladder evacuation (i.e. intermittent catheterization, condom urinal, reflex micturition, transurethral catheter, suprapubic catheter, sacral bladder stimulator, neuromodulation)
Time frame: year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
number of annual symptomatic urinary tract infections
Time frame: time 0
gender, age, type of neurogenic bladder dysfunction, duration of neurogenic bladder dysfunction
Swiss Paraplegic Research, Nottwil
Network
Effects of Bladder Management on Health-related Quality of Life in Patients With Neurogenic Bladder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05312138
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03472599
Central Nervous System Diseases, Female Urogenital Diseases
Syracuse, New York, United States
View Trial DetailsNCT04528784
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Limerick, LK, Ireland
View Trial DetailsNCT05681936
Central Nervous System Diseases, Degenerative Cervical Spinal Stenosis
Zurich, Switzerland
View Trial Details